Thilo Burkard
Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE).
Sudano I, Mach F, Moccetti T, Burkard T, Fahe C, Delabays A, Rickli H, Keller P, Dopheide J, Bodenmann S, Fiolka T, Ehret G, Spirk D. Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE). Front Cardiovasc Med 2022; 9:953040.
Jul 15, 2022Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE).
Jul 15, 2022Front Cardiovasc Med 2022; 9:953040
Sudano Isabella, Mach François, Moccetti Tiziano, Burkard Thilo, Fahe Christian, Delabays Alain, Rickli Hans, Keller Pierre-Fréderic, Dopheide Jörn, Bodenmann Sereina, Fiolka Tom, Ehret Georg, Spirk David
Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial
Huijts M, Brunner-La Rocca H, Pfisterer M, Schindler R, Maeder M, Muzzarelli S, Burkard T, Duits A, van Oostenbrugge R, TIME-CHF Investigators. Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial. Eur J Heart Fail 2013; 15:699-707.
Feb 5, 2013Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial
Feb 5, 2013Eur J Heart Fail 2013; 15:699-707
Huijts Marjolein, Brunner-La Rocca Hans-Peter, Pfisterer Matthias E, Schindler Ruth, Maeder Micha, Muzzarelli Stefano, Burkard Thilo, Duits Annelien, van Oostenbrugge Robert J, TIME-CHF Investigators
Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy
Muzzarelli S, Brunner-La Rocca H, Pfisterer M, Burkard T, Julius B, Nietlispach F, Rickli H, Toggweiler S, Maeder M, TIME-CHF Investigators. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy. Am J Cardiol 2011; 109:693-8.
Dec 5, 2011Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy
Dec 5, 2011Am J Cardiol 2011; 109:693-8
Muzzarelli Stefano, Brunner-La Rocca Hans-Peter, Pfisterer Matthias Emil, Burkard Thilo, Julius Barbara, Nietlispach Fabian, Rickli Hans, Toggweiler Stefan, Maeder Micha, TIME-CHF Investigators